Several studies have shown that in osteolytic bone metastases, bone-derived chemokines and growth factors as chemoattractants, such as monocyte chemoattractant protein 1 and stromal cell-derived factor 1, could attract tumor cells to bone. Here, CCL2 is linked to neoplasm.